Linscott Walt Addison 4
4 · Indaptus Therapeutics, Inc. · Filed Oct 10, 2024
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-09+75,000→ 75,000 totalExercise: $1.10Exp: 2034-10-09→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.